New neural insights into processing uncertainty in obsessive-compulsive disorder

Obsessive-compulsive disorder (OCD) is a neurological disorder characterized by repeated behaviors such as cleaning and checking despite clear objective evidence of cleanliness, orderliness, and correctness. Although the disease is often mischaracterized as a disorder of “fussiness,” the disorder actually stems from difficulty in processing uncertainty. However, the neural underpinnings of that aberrant processing remains unknown.

Now, a new study 新しいタブ／ウィンドウで開く in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 新しいタブ／ウィンドウで開く, published by Elsevier, uses brain imaging to get a closer look at the underpinnings of uncertainty processing in OCD.

The authors, led by Valerie Voon, PhD, from the University of Cambridge, studied a group of patients with OCD, another group of patients with severe OCD who had undergone a therapeutic surgical procedure called capsulotomy, which is thought to decrease OCD-related brain activity, and healthy controls. In addition to investigating brain processing in OCD, the researchers also wanted to examine the effects of capsulotomy on processing.

Dr. Voon explained, “We used a simple card gambling task like that commonly used in drinking games. Participants faced with an open card simply bet whether they thought the next card would be higher or lower than the open card. At the extremes, with high or low open cards, certainty is high, but uncertainty was much higher with cards near the middle of the deck.”

For the functional magnetic resonance imaging (fMRI) experiments, the researchers focused on brain areas implicated in decision making, namely the dorsal anterior cingulate cortex (dACC) and the anterior insula (AI). Participants with OCD displayed aberrant activity in this circuitry compared to healthy controls while determining certainty.

Dr. Voon said, “Critically, patients with OCD showed slower decision making, but only when the outcomes were more certain. Because these impairments appeared in both the OCD patients and those who had improved after capsulotomy surgery, that suggests this cognitive mechanism might be a core feature underlying why OCD develops, irrespective of how severe the symptoms might be.”

Dr. Voon added, “The imaging data may provide a representation of how OCD patients might struggle with their symptoms. Whereas healthy individuals might be able to say, 'this is clean' and stop cleaning, people with OCD might struggle with that sense of certainty, and perhaps spend more time wondering 'is this still a bit dirty, or is this clean enough,' and clean further.”

The findings make clear that OCD is not a disorder of over-cleanliness but one of disordered brain processing of certainty.

Cameron Carter, MD, Editor of Biological Psychiatry: Cognitive Neuroscience and Neuroimaging, said of the work, “This very interesting study provides an important new perspective on the mechanism underlying the disabling symptoms of OCD and suggests that developing new therapies targeting uncertainty processing in the disorder, as well as the neural systems underlying these processes, such as the dACC and AI, may offer new hope to those suffering from this difficult to treat and disabling disorder.”

---

Notes for editors

The article is "Evidence Accumulation and Neural Correlates of Uncertainty in Obsessive-Compulsive Disorder," by Yi-Jie Zhao, Yingying Zhang, Qianfeng Wang, Luis Manssuer, Hailun Cui, Qiong Ding, Bomin Sun, Wenjuan Liu, and Valerie Voon (https://doi.org/10.1016/j.bpsc.2023.05.011 新しいタブ／ウィンドウで開く). It appears as an Article in Press in Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 新しいタブ／ウィンドウで開く, published by Elsevier.

It is openly available at https://www.biologicalpsychiatrycnni.org/article/S2451-9022(23)00147-7/fulltext 新しいタブ／ウィンドウで開く.

Copies of this paper are also available to credentialed journalists upon request; please contact Rhiannon Bugno at [email protected] 新しいタブ／ウィンドウで開く. Journalists wishing to interview the authors may contact Valerie Voon at [email protected] 新しいタブ／ウィンドウで開く or Yiejie Zhao at [email protected] 新しいタブ／ウィンドウで開く.

The authors’ affiliations and disclosures of financial and conflicts of interests are available in the article.

Cameron S. Carter, MD, is Professor of Psychiatry and Psychology and Director of the Center for Neuroscience at the University of California, Davis. His disclosures of financial and conflicts of interests are available here 新しいタブ／ウィンドウで開く.

About Biological Psychiatry: Cognitive Neuroscience and Neuroimaging

Biological Psychiatry: Cognitive Neuroscience and Neuroimaging 新しいタブ／ウィンドウで開く is an official journal of the Society of Biological Psychiatry 新しいタブ／ウィンドウで開く, whose purpose is to promote excellence in scientific research and education in fields that investigate the nature, causes, mechanisms and treatments of disorders of thought, emotion, or behavior. In accord with this mission, this peer-reviewed, rapid-publication, international journal focuses on studies using the tools and constructs of cognitive neuroscience, including the full range of non-invasive neuroimaging and human extra- and intracranial physiological recording methodologies. It publishes both basic and clinical studies, including those that incorporate genetic data, pharmacological challenges, and computational modeling approaches. The 2022 Journal Impact Factor^TM score, from Clarivate, for Biological Psychiatry: Cognitive Neuroscience and Neuroimaging is 5.9 (Journal Citation Reports™, Clarivate™, 2023). www.sobp.org/bpcnni 新しいタブ／ウィンドウで開く

エルゼビアについて

エルゼビアは情報分析を専門としたグローバル企業として、研究者や医療専門家の方々を支援し、社会にとっての利益最大化に向けて、科学や医療の進展を支えています。これは、信頼できるエビデンスによるコンテンツと高度なAI対応によるデジタル技術に基づく革新的なソリューションにより、知見の集積や重要な意思決定を支援することで実現されています。

エルゼビアは、全世界で9,700人の従業員（うち技術者2,300人以上）を抱え、140年以上にわたって、研究者、図書館員、アカデミックリーダー、資金提供者、政府、研究開発集約型企業、医師、看護師、将来の医療専門家、教育者など研究・医療分野におけるパートナーの重要な活動を支援してきました。エルゼビアが刊行する3,000誌以上の科学ジャーナルと代表的な参考書には、The Lancet 新しいタブ／ウィンドウで開く、Cell Press 新しいタブ／ウィンドウで開くおよびGray’s Anatomyなどをはじめとする、各分野を代表する主要なタイトルが含まれています。 エルゼビア・ファンデーション 新しいタブ／ウィンドウで開くとの活動を通し、私たちがサービスを提供する地域社会と連携して、開発途上国を含む世界中の医学、研究、医療分野における、インクルージョン＆ダイバーシティ（I&D）の改善に努めています。

エルゼビアは、専門家および企業向けの情報分析および意思決定ツールのグローバルプロバイダーであるRELX Group 新しいタブ／ウィンドウで開くの一事業を担っています。エルゼビアの事業内容、デジタルソリューション、コンテンツなどの詳細については、www.elsevier.comをご覧ください。